Abstract
Cardiovascular disease is the leading cause of morbidity/mortality in the western world. Atherosclerotic plaques are the main culprit of myocardial infarction and stroke. Magnetic resonance imaging is an emerging clinical tool for the detection and characterization of atherosclerotic plaques. Target-specific molecular MR contrast agents allow the characterization of plaques on a molecular and cellular level. This chapter starts with an overview of the biological changes leading to atherosclerosis. The basic principles of molecular MR are discussed and different MR sequences are introduced. This chapter concludes with a discussion of clinically-feasible aortic, carotid and coronary MR imaging techniques.
| Original language | English |
|---|---|
| Title of host publication | Biomedical Imaging |
| Subtitle of host publication | Applications and Advances |
| Publisher | Elsevier Inc. |
| Pages | 214-234 |
| Number of pages | 21 |
| ISBN (Print) | 9780857091277 |
| DOIs | |
| State | Published - Feb 2014 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Atherosclerosis
- Cardiovascular magnetic resonance imaging
- Contrast agents
Fingerprint
Dive into the research topics of 'Cardiovascular magnetic resonance imaging (MRI)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver